Advances in microbial physiology. Volume eighty five /

Bibliographic Details
Corporate Author: ScienceDirect (Online service)
Other Authors: Poole, Robert K. (Editor), Kelly, David J. (Editor)
Format: eBook
Language:English
Published: London, England ; Cambridge, MA ; San Diego, CA : Academic Press, an imprint of Elsevier, [2024]
Edition:First edition
Subjects:
Online Access:Connect to the full text of this electronic book

MARC

Tag First Indicator Second Indicator Subfields
LEADER 00000cam a2200000 i 4500
001 in00005774040
005 20260327180725.2
006 m o d
007 cr |||||||||||
008 241103t20242024enka ob 000 0 eng d
040 |a SFB  |b eng  |e rda  |e pn  |c SFB  |d OCLCO  |d OCLCQ  |d OCLCL  |d GZM  |d OCLCO  |d YDX  |d OPELS  |d UKAHL  |d UKMGB 
015 |a GBC562450  |2 bnb 
016 7 |a 300567168  |2 Uk 
019 |a 1437983525 
020 |a 0443295433  |q (electronic bk.) 
020 |a 9780443295430  |q (electronic bk.) 
020 |z 0443295425 
020 |z 9780443295423 
024 8 |a CIPO000242999 
035 |a (OCoLC)1472995246  |z (OCoLC)1437983525 
050 4 |a QR92.M5 
082 0 4 |a 615.329  |2 23 
049 |a TXAM 
245 0 0 |a Advances in microbial physiology.  |n Volume eighty five /  |c edited by Robert K. Poole, David J. Kelly. 
246 3 |a Advances in microbial physiology.  |n Volume 85 
250 |a First edition 
264 1 |a London, England ;  |a Cambridge, MA ;  |a San Diego, CA :  |b Academic Press, an imprint of Elsevier,  |c [2024] 
264 4 |c ©2024 
300 |a 1 online resource (xi, 323 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references at the end of each chapter. 
505 0 |a Front Cover -- Advances in Microbial Physiology -- Copyright -- Contents -- Contributors -- Preface -- Chapter One: The genetic basis of predation by myxobacteria -- 1 The myxobacteria -- 1.1 Myxobacterial diversity and distribution -- 1.1.1 Myxobacterial taxonomy -- 1.1.2 Myxobacterial distribution -- 1.2 Myxobacterial multicellular behaviours -- 1.2.1 Swarming motility -- 1.2.2 Multicellular development -- 1.2.3 Multicellular predation -- 2 Myxobacterial predatory activity -- 2.1 Prey range -- 2.1.1 Breadth of predatory activity -- 2.1.2 Outcomes/prey responses -- 2.1.3 Evolutionary/ecological aspects -- 2.2 Contact-dependent killing -- 2.2.1 The kil system -- 2.2.2 Single-cell analyses -- 2.3 Secreted factors -- 2.3.1 Commons -- 2.3.2 Cooperativity -- 2.3.3 Ecological considerations -- 3 The genetic basis of predatory activity -- 3.1 Molecular genetic studies -- 3.2 'Omic studies -- 4 Applications in biological control -- 4.1 Sectors -- 4.1.1 Food systems and agriculture -- 4.1.2 Medicine -- 4.2 Strains for biological control -- 4.2.1 Selection -- 4.2.2 Evolution -- 4.2.3 Genetic modification -- 4.2.4 Negatively correlated genes -- 5 Perspectives -- 5.1 The role of models -- 5.2 Evolve, engineer and/or select -- References -- Chapter Two: Utilisation of low methane concentrations by methanotrophs -- 1 Introduction -- 2 Methane oxidation systems -- 2.1 The known methane oxidation enzymes -- 2.2 The pMMO -- 3 Possibility of a high affinity pMMO -- 3.1 Environmental samples and pure cultures -- 3.2 Whole cell methane consumption kinetics -- 3.2.1 pMMO expression -- 3.2.2 Specific affinity in relation to the pMMO -- 3.2.3 The intracytoplasmic membranes (ICMs) -- 3.2.4 The provision of electrons to the pMMO in the aerobic methanotrophs -- 3.2.5 Diffusion of O2 and methane -- 3.2.5 Other factors -- 3.3 Summary: high affinity pMMO. 
505 8 |a 4 Growth on low methane concentrations -- 4.1 Growth on 200-1000 ppm methane -- 4.1.1 Nongrowth-associated maintenance energy (NGAME) -- 4.1.2 Cell size -- 4.1.3 Metabolic efficiency -- 4.1.4 Presence of a divergent pMMO -- 4.2 Growth on 100 ppm and below methane -- 4.2.1 Cometabolism -- 4.2.2 NGAME -- 4.3 Summary: growth on low methane concentrations -- 5 Strategies for decreasing methane to slow global warming -- 6 Future Work -- 6.1 Isolation and characterisation of new aerobic methanotrophs -- 6.2 Adaptive laboratory evolution -- 6.3 MMO engineering -- 6.4 Methane utilisation in the environment -- 6.5 Engineered technology -- 7 Summary -- References -- Chapter Three: The globins of cyanobacteria and green algae: An update -- 1 Introduction -- 1.1 Structural considerations -- 1.2 Chemical considerations -- 2 The haem-binding globins of cyanobacteria and green algae -- 2.1 Cyanobacterial haem-binding globins -- 2.1.1 T haemoglobins -- 2.1.1.1 Nostoc commune UTEX 584 GlbN -- 2.1.1.2 Synechocystis sp. PCC 6803 GlbN -- 2.1.1.3 Synechococcus sp. PCC 7002 GlbN -- 2.1.1.4 Other TrHbs -- 2.1.2 S haemoglobins -- 2.1.3 M haemoglobins -- 2.2 Chlorophytic haem-binding globins -- 2.2.1 T haemoglobins -- 2.2.1.1 Chlamydomonas TrHb1s -- 2.2.1.2 Other TrHbs -- 2.2.2 M haemoglobins -- 3 The linear tetrapyrrole-binding globins of cyanobacteria and algae -- 4 The RsbR-like proteins -- 5 Phylogeny of the five-branch globin superfamily -- 6 Applications -- 7 Concluding remarks -- Acknowledgement -- References -- Chapter Four: Role of sulfidogenic members of the gut microbiota in human disease -- 1 The human gut microbiome -- 2 Diet and dysbiosis -- 3 Hydrogen sulfide in the gut -- 3.1 Endogenous H2S production -- 3.2 Microbial H2S production -- 3.3 Effects of H2S -- 4 Bilophila wadsworthia -- 4.1 Energy metabolism -- 4.1.1 Taurine metabolism. 
505 8 |a 4.1.2 Dissimilatory sulfite reduction -- 5 Sulfidogenic bacteria and disease -- 5.1 Diseases associated with intestinal bacterial overgrowth -- 5.1.1 Inflammatory bowel diseases -- 5.1.2 Colorectal cancer -- 5.1.3 Metabolic disorders -- 5.1.4 Central nervous system-related disorders -- 5.1.4.1 Parkinson's disease -- 5.1.4.2 Other disorders -- 5.1.5 Hypertension -- 5.2 Bacteremia and infection -- 5.2.1 Virulence features -- 6 Conclusions -- Acknowledgments -- References -- Chapter Five: Staphylococcus aureus response and adaptation to vancomycin -- 1 Introduction -- 2 VISA and hVISA definitions -- 3 Clinical impact of VISA -- 4 Vancomycin mode of action and VISA phenotypes -- 5 Transient VISA -- 6 VISA mutations -- 7 Collateral susceptibility to antimicrobials -- 8 Collateral effects of VISA on phage susceptibility -- 9 Epistasis and stability -- 10 Perspectives -- Acknowledgement -- References -- Further reading -- Chapter Six: The past, present and future of polymicrobial infection research: Modelling, eavesdropping, terraforming and other stories -- 1 Introduction -- 1.1 Tapping into 'microbial dark matter' -- 1.2 The airway microbiota -- 1.2.1 Understanding the healthy respiratory microbiome -- 1.2.2 The respiratory microbiota in disease -- 1.3 The skin microbiota -- 1.3.1 The microbiota of healthy skin -- 1.3.2 The wound microbiota -- 2 Laboratory endeavours -- 2.1 Models for the study of polymicrobial infections -- 2.2 Models of CF lung microbiology -- 2.3 Chronic wound models -- 2.4 Ex vivo models -- 2.5 Invertebrate models -- 2.6 Vertebrate models -- 3 Imaging: direct observation and heterogeneity -- 4 The extracellular interactome: P. aeruginosa as micro-architect of the lung -- 5 Interspecies relations: social and antisocial microbes in infection -- 5.1 Bacterial interactions -- 5.1.1 P. aeruginosa and S. aureus. 
505 8 |a 5.1.2 The other neighbours of P. aeruginosa -- 5.2 Interkingdom interactions: bacteria and fungi -- 5.2.1 Interactions between C. albicans and P. aeruginosa -- 5.2.2 Interactions between C. albicans and S. aureus -- 5.2.3 Interactions between C. albicans and Streptococcus species -- 5.2.4 Interactions between A. fumigatus and P. aeruginosa -- 5.2.5 Interactions between A. fumigatus and others -- 5.3 The diverse forms of interspecies communication -- 6 Understanding the ecology of inter-species interactions: computational approaches and perspectives -- 6.1 The joys and miseries of 'curated' databases -- 6.2 Mathematical models -- 6.3 The current state of the art: rethinking levels of organisation -- 7 Conclusions -- Acknowledgements -- References -- Back Cover. 
588 |a Description based on online resource; title from PDF title page (Science Direct, viewed August 26, 2025). 
650 0 |a Microbiology. 
650 0 |a Microorganisms  |x Physiology. 
650 2 |a Microbiology 
650 6 |a Micro-organismes  |x Physiologie. 
650 6 |a Microbiologie. 
650 7 |a microbiology.  |2 aat 
650 7 |a Microbiology  |2 fast 
650 7 |a Microorganisms  |x Physiology  |2 fast 
655 7 |a Electronic books.  |2 local 
700 1 |a Poole, Robert K.,  |e editor.  |1 https://id.oclc.org/worldcat/entity/E39PCjvDr9pQYtRxQ4Yxy4Ftcd 
700 1 |a Kelly, David J.,  |e editor.  |1 https://id.oclc.org/worldcat/entity/E39PCjFgwFkfV4wQQDyDkQtJwy 
710 2 |a ScienceDirect (Online service) 
776 0 8 |c Original  |z 0443295425  |z 9780443295423  |w (OCoLC)1426995202 
776 0 8 |i Print version :  |z 9780443295423 
856 4 0 |u http://proxy.library.tamu.edu/login?url=https://www.sciencedirect.com/science/bookseries/00652911/85  |z Connect to the full text of this electronic book  |t 0 
936 |a BATCHLOAD 
955 |a Elsevier ScienceDirect 2026-2027 
994 |a 92  |b TXA 
999 f f |i cf03855e-89a9-41b3-ac7d-8335ae1015e2  |s de05b6fa-3516-42de-a3cd-3f521332683c  |t 0 
952 f f |a Texas A&M University  |b College Station  |c Electronic Resources  |s www_evans  |d Available Online  |t 0  |e QR92.M5   |h Library of Congress classification 
998 f f |a QR92.M5   |t 0  |l Available Online